Analysts expect Dolby Laboratories, Inc. (NYSE:DLB) to report $0.43 earnings per share for the current fiscal quarter, according to Zacks Investment Research. Four analysts have provided estimates for Dolby Laboratories’ earnings, with estimates ranging from $0.42 to $0.44. Dolby Laboratories reported earnings per share of $0.45 during the same quarter last year, which suggests a negative year over year growth rate of 4.4%. The firm is expected to issue its next quarterly earnings report on Wednesday, October 24th.

According to Zacks, analysts expect that Dolby Laboratories will report full-year earnings of $2.93 per share for the current financial year, with EPS estimates ranging from $2.92 to $2.94. For the next fiscal year, analysts expect that the business will report earnings of $3.10 per share, with EPS estimates ranging from $3.03 to $3.16. Zacks’ EPS calculations are an average based on a survey of research analysts that cover Dolby Laboratories.

Dolby Laboratories (NYSE:DLB) last announced its earnings results on Wednesday, July 25th. The electronics maker reported $0.92 earnings per share for the quarter, beating analysts’ consensus estimates of $0.69 by $0.23. The firm had revenue of $317.45 million for the quarter, compared to analyst estimates of $317.65 million. Dolby Laboratories had a net margin of 8.18% and a return on equity of 12.95%. The company’s revenue for the quarter was up 3.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.73 EPS.

Several equities research analysts recently commented on the stock. Zacks Investment Research raised shares of Dolby Laboratories from a “hold” rating to a “buy” rating and set a $73.00 price objective on the stock in a research note on Tuesday, June 19th. ValuEngine lowered shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Wednesday, July 11th. B. Riley boosted their price objective on shares of Dolby Laboratories from $61.00 to $69.00 and gave the stock a “neutral” rating in a research note on Thursday, July 26th. R. F. Lafferty assumed coverage on shares of Dolby Laboratories in a research note on Wednesday, September 5th. They set a “buy” rating and a $81.00 price objective on the stock. Finally, Barrington Research reissued a “buy” rating and set a $78.00 price objective on shares of Dolby Laboratories in a research note on Thursday, July 26th. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company. Dolby Laboratories presently has a consensus rating of “Buy” and an average target price of $74.20.

NYSE:DLB traded up $0.23 during mid-day trading on Tuesday, hitting $69.53. 472,811 shares of the company’s stock were exchanged, compared to its average volume of 316,105. Dolby Laboratories has a one year low of $56.50 and a one year high of $74.29. The firm has a market capitalization of $7.21 billion, a P/E ratio of 31.60, a PEG ratio of 2.44 and a beta of 0.80.

In related news, major shareholder Dagmar Dolby sold 100,000 shares of the business’s stock in a transaction dated Thursday, June 28th. The shares were sold at an average price of $61.93, for a total transaction of $6,193,000.00. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Kevin J. Yeaman sold 15,000 shares of the business’s stock in a transaction dated Wednesday, August 1st. The stock was sold at an average price of $64.48, for a total transaction of $967,200.00. The disclosure for this sale can be found here. Insiders have sold 527,000 shares of company stock worth $33,202,939 in the last three months. 43.80% of the stock is currently owned by insiders.

Several hedge funds and other institutional investors have recently modified their holdings of DLB. Disciplined Growth Investors Inc. MN lifted its stake in shares of Dolby Laboratories by 86.3% in the second quarter. Disciplined Growth Investors Inc. MN now owns 1,344,217 shares of the electronics maker’s stock worth $82,925,000 after buying an additional 622,618 shares in the last quarter. Allianz Asset Management GmbH lifted its stake in shares of Dolby Laboratories by 107.3% in the first quarter. Allianz Asset Management GmbH now owns 1,167,119 shares of the electronics maker’s stock worth $74,182,000 after buying an additional 604,109 shares in the last quarter. Janus Henderson Group PLC lifted its stake in shares of Dolby Laboratories by 16.2% in the second quarter. Janus Henderson Group PLC now owns 3,801,592 shares of the electronics maker’s stock worth $234,517,000 after buying an additional 530,188 shares in the last quarter. Summit Trail Advisors LLC lifted its stake in shares of Dolby Laboratories by 4,489.0% in the first quarter. Summit Trail Advisors LLC now owns 518,562 shares of the electronics maker’s stock worth $519,000 after buying an additional 507,262 shares in the last quarter. Finally, FMR LLC lifted its stake in shares of Dolby Laboratories by 19.7% in the second quarter. FMR LLC now owns 2,480,454 shares of the electronics maker’s stock worth $153,019,000 after buying an additional 408,054 shares in the last quarter. Hedge funds and other institutional investors own 56.23% of the company’s stock.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices. The company develops and licenses its audio technologies, including Dolby Digital Plus for digital television, mobile, and Internet-based services; Dolby Digital, a digital audio coding technology that provides multichannel sound in the home; and AAC & HE-AAC, an audio coding technologies used to broadcast, download, and streaming content.

Further Reading: Technical Analysis of Stocks and What It Means

Get a free copy of the Zacks research report on Dolby Laboratories (DLB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.